Adaptimmune Therapeutics shares owned by Wealth Enhancement Advisory Services
Quarter-by-quarter ownership of Adaptimmune Therapeutics (ADAP) shares owned by Wealth Enhancement Advisory Services
from 13F filings
Historical chart of Wealth Enhancement Advisory Services investment in Adaptimmune Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Adaptimmune Therapeutics held by Wealth Enhancement Advisory Services consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Adaptimmune Therapeutics by Wealth Enhancement Advisory Services
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $5.7k | 41k | 0.14 |
| 2025-06-30 | $2.7k | 11k | 0.25 |
| 2025-03-31 | $5.3k | 27k | 0.20 |
| 2024-12-31 | $14k | 27k | 0.54 |
| 2024-06-30 | $34k | 35k | 0.97 |
| 2024-03-31 | $51k | 32k | 1.58 |
| 2023-12-31 | $26k | 32k | 0.79 |
| 2023-09-30 | $24k | 30k | 0.78 |
More positions owned by Wealth Enhancement Advisory Services
View all positions for Wealth Enhancement Advisory Services